PPARG and lung cancer: For instance, EGR1, JUN, PPARG, and RELA may have a beneficial effect in lung cancer, related to inhibition of tumor proliferation and metastasis, induction of apoptosis, and sensitization for chemotherapeutic drugs (29–37).